Advanced Filters
noise

Santiao de Compostela, Spain Clinical Trials

A listing of Santiao de Compostela, Spain clinical trials actively recruiting patients volunteers.

Found 91 clinical trials
M Manuel Taboada

Flexible Tip Bougie vs Tube With Stylet for Intubation With Videolaryngoscopy.

Although VLs improve glottic visualization, on many occasions it may not be accompanied by intubation at the first attempt, because the endotracheal tube has to pass a sharp angle to enter the trachea. To avoid this limitation, a new flexible tip bougie is designed to flexibly navigate the distal tip …

18 - 90 years of age All Phase N/A
J Javier Gonzalez Perez

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

To compare the rate of myopia progression of contact lenses utilising S.T.O.P.® technology against MiSight® contact lenses.

8 - 14 years of age All Phase N/A
J Jose Mª Ribera, Dr

Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults

After consolidation therapy adult patients (≥18 yr) with Ph-negative ALL will be treated with continuation chemotherapy or allogeneic hematopoietic stem cell transplantation (alloHSCT) according to both measurable residual disease (MRD) and results of genetic study performed at baseline.

18 - 60 years of age All Phase N/A
M Mario Pérez Sayáns, PhD

Role of the Dentist in the Control of the Alcoholic Habit in Patients With Potentially Malignant Oral Lesions

Introduction: Alcohol is the most consumed psychoactive substance, its consumption is very prevalent and there is a low perception of the risk it poses in our society. Alcohol is a risk factor and a causal factor for multiple pathologies, including cancer and potentially malignant oral lesions (LOPM). The dentist can …

40 years of age All Phase N/A
M Mario Pérez Sayáns, PhD

Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model

The clinical study aims to assess the osteogenic effects of Galibone+ in bone regeneration post-extraction of impacted mandibular third molars.

18 - 50 years of age All Phase 4
M Maria Victoria Mateos Manteca, MD

Efficacy and Safety of Anitocabtagene Autoleucel in Participants With Newly Diagnosed Multiple Myeloma (GEM-AnitoFIRST)

The goal of this clinical trial is to learn if anitocabtagene autoleucel following induction therapy works to treat adult participants with newly diagnosed multiple myeloma. The main objectives of this clinical trial are: To determine the incidence and severity of all adverse events (AEs). To determine the proportion of patients …

18 - 80 years of age All Phase 2
M Maria Jose Teijeiro

Small Macular Holes Treated With Air

Non-inferiority trial comparing intraocular air and gas tamponade for closure of macular holes.

18 years of age All Phase N/A
G Gabriele Capurso, PhD

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

This will a be an open label, multicentre, randomized, controlled study in patients with unresectable pancreatic cancer, locally advanced or metastatic, with significant weight loss, and the tumour located in the head of the pancreas associated with dilated main pancreatic duct. Pancreatic Exocrine Replacement Therapy (PERT) in these patients will …

18 years of age All Phase 4
B Bonadies

Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)

This is a randomized, parallel-group, double-blind, placebo-controlled multicenter phase 2b/3 study with an adaptive seamless design. The goal fo this study is to determine if an investigational drug, Zelpultide Alfa, can reduce the occurrence of Bronchopulmonary Dysplasia (BPD) in extremely premature babies. The study comprises 2 parts: Part 1: Phase …

- 96 years of age All Phase 2/3
P Pablo Javier Mozas Fernández, Dr

CHOP Plus Mosunetuzumab as First Line in Patients With Richter´s Syndrome: a Phase II Study of the Spanish Group of CLL

The goal of this clinical trial is to learn if drug Mosunetuzumab works to treat Richter´syndrome . It will also learn about the safety of drug Mosunetuzumab. The main questions it aims to evaluate the efficacy of mosunetuzumab combined with CHOP (M-CHOP) after the end of induction in patients with …

18 - 79 years of age All Phase 2

Simplify language using AI